Algeria Medical Device Registration & ANPP Homologation Support
Navigate Algeria's modernised regulatory landscape with confidence. NexorTest Technologies delivers end-to-end consulting for ANPP market authorization, quality control laboratory testing, CE marking pathways, MIPH import licensing and local Authorized Representative appointment bringing your devices into one of North Africa's largest healthcare markets.
ANPP Regulated Market
Algeria’s Agence Nationale des Produits Pharmaceutiques (ANPP) oversees all medical device homologation under Health Law 18-11 and Decree 19-190.
CE Marking Preferred
Devices with valid CE marking from EU Notified Bodies benefit from streamlined review under Algeria’s EU aligned four class system.
ANPP Quality Control Lab
ANPP’s control laboratory (the former LNCPP, now absorbed into the agency) may test samples of higher risk devices to verify safety and performance.
Understanding Algeria's Medical Device Regulatory Framework
Algeria's medical device system is administered by the ANPP under the Ministry of Pharmaceutical Industry, following an EU aligned classification approach established by Health Law 18-11 (2018) and implemented through Decree 19-190 and subsequent homologation decrees.
Algeria is one of the most significant medical device markets in North Africa, serving a population of over 45 million people with a healthcare system that continues to expand and modernise. Regulation is governed at national level, with the National Agency for Pharmaceutical Products (Agence Nationale des Produits Pharmaceutiques, ANPP) functioning as the primary authority responsible for evaluating and granting homologation (market authorization) for medical devices and IVDs.
ANPP was created on 2 July 2018 and organised by Decree No. 19-190 (July 2019). It progressively replaced the former General Directorate of Pharmacy and Health Equipment (DGPES) and absorbed the national control laboratory (LNCPP), consolidating registration, evaluation and quality control testing within a single agency. The legal foundation rests on Health Law 18-11 (2018), with Executive Decrees 20-324 (2020) and 23-101 (2023) defining the exact modalities and transitional grace periods for device homologation.
Algeria operates a dual regulator model the ANPP handles technical product registration and issues the homologation decision (Décision d’Enregistrement), while the Ministry of Pharmaceutical Industry (MIPH) oversees establishment licensing and issues the import authorization (Agrément d’Importation). Manufacturers need both to place a device on the market and clear it through customs.
The classification system is closely aligned with the European Union model four risk based classes (I, IIa, IIb, III) so manufacturers already holding CE marking are well positioned to navigate homologation efficiently. A registration is valid for five years, and the sector is modernising rapidly, with a GS1 serialization mandate effective 1 January 2027 and a 2025 interministerial framework introducing regulatory reliance and mutual recognition.
Algeria Medical Device Registration Services
NexorTest Technologies delivers comprehensive consulting across every stage of Algeria medical device registration from initial strategy through ANPP homologation and ongoing post-market compliance.
ANPP Market Authorization
We prepare, compile and submit your homologation dossier to the ANPP device descriptions, intended use statements, safety and performance data, French and Arabic labelling, and supporting certificates and act as your interface with ANPP reviewers to keep the application moving.
CE Marking Pathway
Algeria strongly favours devices carrying valid CE marking from EU Notified Bodies. We help you leverage existing European certificates to accelerate entry, or build a parallel EU MDR / IVDR roadmap through gap analysis, technical file preparation and Notified Body coordination.
ANPP Lab Testing Support
ANPP’s quality control laboratory (the former LNCPP, now integrated into the agency) may request samples for independent testing. We coordinate protocols, sample preparation, logistics and results interpretation for biocompatibility, electrical safety, sterility and performance verification.
Local Representative Services
Foreign manufacturers cannot hold registrations directly and must appoint a licensed local Algerian importer / Authorized Representative. Through our vetted partner network we manage appointment, ANPP and MIPH correspondence, traceability and field safety corrective actions.
MIPH Import Licensing
Importing devices requires an establishment authorization (Agrément d’Importation) from the Ministry of Pharmaceutical Industry, separate from ANPP homologation. We prepare import permit applications, coordinate with customs, and align French/Arabic labelling and duty classification.
Post-Market Surveillance
We establish vigilance systems, adverse event reporting, periodic safety updates and complaint handling aligned with ANPP requirements plus renewal management and readiness for the GS1 serialization mandate and Algeria’s national electronic tracking platform.
Algeria Medical Device Classification System
Algeria follows an EU aligned, risk based classification under Health Law 18-11, sorting devices into four classes by intended use, duration of contact and degree of invasiveness.
| Classification | Risk Level | Device Examples | Key Requirements |
|---|---|---|---|
| Class I | Low | Non-sterile bandages, tongue depressors, reusable surgical instruments, hospital beds, manual wheelchairs | Technical file, declaration of conformity, CE marking (preferred), Free Sale Certificate, ISO 13485 |
| Class IIa | Low Moderate | Powered diagnostic equipment, hearing aids, surgical gloves, dental crowns, blood pressure monitors | CE marking certificate, ISO 13485, technical documentation, clinical data, risk management (ISO 14971) |
| Class IIb | Moderate High | Ventilators, infusion pumps, dialysis machines, surgical lasers, external defibrillators | CE marking, ISO 13485, ISO 14971, comprehensive clinical evaluation, ANPP sample testing (possible) |
| Class III | High | Cardiac stents, hip implants, pacemakers, drug-eluting devices, spinal fixation systems | CE marking, full clinical investigation data, ISO 13485, ISO 14971, ANPP testing, post-market surveillance plan |
How to Register a Medical Device in Algeria
The Algeria medical device registration process runs through several structured phases, from regulatory strategy to ANPP homologation and post-market compliance. NexorTest guides you through each step.
Regulatory Strategy & Gap Analysis
We confirm your device class under Algeria’s EU aligned system, review existing CE marking and ISO 13485 certificates, identify documentation gaps and define a tailored strategy that accounts for ANPP requirements, testing probability and your target timeline.
Appoint Local Authorized Representative
Foreign manufacturers must appoint a licensed local Algerian importer / Authorized Representative before filing. We select and appoint a qualified partner who serves as your official liaison with the ANPP, MIPH and customs authorities.
Technical File Preparation
We compile a homologation dossier compliant with Health Law 18-11 and Decrees 20-324 / 23-101 device specifications, intended use, manufacturing documentation, ISO 14971 risk management, clinical evaluation, French/Arabic labelling, and CE / ISO 13485 certificates.
ANPP Submission & Review Management
The dossier is submitted to the ANPP through your local representative. We manage all ANPP interactions, respond to reviewer queries, provide supplementary data and track application status against ANPP’s homologation timeline.
ANPP Laboratory Testing Coordination
When ANPP’s control laboratory requests samples for independent testing, we coordinate preparation, shipping, protocol communication and results review, ensuring samples meet all packaging, labelling and documentation requirements for acceptance.
Homologation & Import Licensing
On successful review and testing, your device receives ANPP homologation (valid five years). We then support the MIPH import authorization, customs documentation, and set up of post-market surveillance and vigilance to maintain compliance.
Why Choose NexorTest for Algeria Medical Device Registration
Specialised expertise in North African regulatory environments, combined with deep knowledge of EU-aligned frameworks, makes NexorTest the partner of choice for companies entering Algeria.
North Africa Regulatory Expertise
Specialised knowledge of Algeria's ANPP-regulated environment, its administrative procedures, French and Arabic documentation requirements, and the modernisation reforms reshaping the market.
Established Local Partner Network
A vetted network of Authorized Representatives and importers in Algeria, giving manufacturers reliable local representation that meets mandatory ANPP and MIPH requirements.
CE Marking & EU MDR Alignment
Deep European Medical Device Regulation expertise so you can leverage CE marking for accelerated entry, with technical files that satisfy both EU and Algerian requirements at once.
End-to-End Process Management
From classification and gap analysis through ANPP submission, laboratory testing, MIPH import licensing and post-market surveillance managed as a single, coordinated engagement.
Accelerated Market Access
Proactive documentation preparation, pre-submission quality reviews and regulatory liaison help minimise administrative delays and achieve homologation on the shortest achievable timeline.
Ongoing Regulatory Intelligence
We track ANPP reforms the 2027 serialization mandate, reliance and mutual recognition frameworks, and local-manufacturing incentives to keep your compliance strategy current.
Algeria Medical Device Registration FAQs
Answers to the most common questions about registering medical devices in Algeria from ANPP homologation and laboratory testing to CE marking and local representation.
How do I register a medical device in Algeria?
Submit a homologation dossier to the National Agency for Pharmaceutical Products (ANPP). You must appoint a licensed local Algerian importer or Authorized Representative and provide technical documentation including CE marking certificates, ISO 13485 certification, clinical evidence and a Free Sale Certificate. ANPP’s control laboratory may request samples for testing. Registrations are valid for five years, and timelines typically run 8-18 months depending on device class.
Who is the medical device regulator in Algeria?
The Agence Nationale des Produits Pharmaceutiques (ANPP), operating under the Ministry of Pharmaceutical Industry, is Algeria’s medical device regulator. Created on 2 July 2018 and organised by Decree 19-190, it progressively replaced the former DGPES and absorbed the LNCPP control laboratory, consolidating registration, evaluation and quality-control testing within a single agency. Separately, the Ministry of Pharmaceutical Industry (MIPH) issues the import authorization (Agrément d’Importation) needed to bring devices through customs.
Is CE marking required for medical devices in Algeria?
CE marking is not legally mandatory in Algeria, but it is strongly preferred. The ANPP’s four class system (I, IIa, IIb, III) is aligned with the EU model, and devices holding valid CE certificates from EU Notified Bodies benefit from a significantly streamlined homologation review. Manufacturers without CE marking can expect longer evaluation timelines and additional documentation requirements in practice, most devices entering the Algerian market carry CE certification.
Do I need a local Authorized Representative in Algeria?
Yes, Foreign manufacturers cannot hold Algerian registrations directly and must appoint a licensed local Algerian importer / Authorized Representative before filing. The representative acts as your legal liaison with the ANPP and MIPH submitting and managing filings, receiving official correspondence, maintaining traceability, and facilitating recalls or field safety corrective actions. NexorTest provides appointment and management services through our vetted Algerian partner network.
How long does ANPP registration take?
Timelines typically run 8-18 months end to end depending on device class and documentation completeness, although the ANPP works to a 90day internal review target once a complete dossier is accepted. Higher-risk devices (Class IIb and III) take longer due to deeper technical review and possible ANPP laboratory sample testing. A complete dossier with valid CE marking and ISO 13485 certificates is the best way to minimise delays. Homologation, once granted, is valid for five years.
What are the latest ANPP regulatory changes to plan for?
Two changes stand out. A GS1 serialization mandate takes effect on 1 January 2027, alongside Algeria’s national electronic tracking platform, so manufacturers should prepare unique device identification and traceability now. And a 2025 interministerial framework introduces regulatory reliance and mutual recognition, which is expected to streamline reviews for devices already approved in reference markets. Executive Decrees 20-324 (2020) and 23-101 (2023) define the current homologation modalities and transitional grace periods. NexorTest tracks these reforms to keep your compliance strategy current.
Ready to Enter the Algerian Medical Device Market?
Partner with NexorTest Technologies for expert ANPP homologation, quality-control testing coordination, MIPH import licensing and complete regulatory support. Start your Algeria medical device registration today.